Broad Institute

JUNE 18, 2024

Simple test for flu could improve diagnosis and surveillance By Allessandra DiCorato June 18, 2024 Breadcrumb Home Simple test for flu could improve diagnosis and surveillance A low-cost CRISPR-based paper strip test distinguishes between influenza types and can be reprogrammed to recognize different viruses including the H5N1 bird flu virus.

Virus 144

Virus RNA Laboratories Medical Schools 144

Drugs.com

JULY 17, 2023

MONDAY, July 17, 2023 (HealthDay Now) -- Parents now have a new long-acting drug to protect their children against respiratory syncytial virus (RSV), a common germ that hospitalizes as many as 3% of children under the age of 1 in the United States.

FDA Approval 100

FDA Approval Virus FDA Hospitals 100

SCIENMAG: Medicine & Health

JANUARY 16, 2024

In early 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a highly contagious and pathogenic virus, made its alarming debut and quickly spread worldwide, causing the novel coronavirus (COVID-19) pandemic that threatened human health and public safety.

Virus 93

Virus Hospitals 93

SCIENMAG: Medicine & Health

JULY 13, 2023

As a result of the COVID-19 pandemic, respiratory syncytial virus (RSV) surges in young children occurred outside the usual November to March season, when immune-based prophylactic is available to protect children at high risk for severe illness.

Hospitals 70

Hospitals Virus 70

SCIENMAG: Medicine & Health

JULY 19, 2023

An article […]

Production 69

Production Hospitals Virus Research 69

The Pharma Data

DECEMBER 17, 2020

(NASDAQ: REGN ) today announced that the New England Journal of Medicine (NEJM) has published initial clinical data from an ongoing seamless Phase 1/2/3 trial of the antibody cocktail casirivimab and imdevimab in non-hospitalized patients with COVID-19. “The investigational cocktail is now available to indicated high-risk U.S.

Hospitals 52

Hospitals Production Clinical Trials Virus 52

The Pharma Data

OCTOBER 30, 2020

(NASDAQ: REGN) received today a recommendation from the independent data monitoring committee (IDMC) for the REGN-COV2 antibody cocktail treatment trials for COVID-19 that the current hospitalized patient trial be modified. About the REGN-COV2 Trial in Hospitalized Patients. Cohort 1A: patients not requiring oxygen.

Hospitals 52

Hospitals Virus Production Clinical Trials 52

Broad Institute

JULY 11, 2024

Targeted drug treatment leads tumor cells to imitate viral infection By Ari Navetta July 11, 2024 Breadcrumb Home Targeted drug treatment leads tumor cells to imitate viral infection Exploiting "viral mimicry," mIDH1 inhibitors trick tumors into thinking they are infected with a virus. paper cited Wu M, Kondo H, et al.

Treatment 72

Treatment Immune Response Drugs Virus 72

The Pharma Data

MARCH 8, 2021

The companies today reported findings on one secondary objective from the Phase 2a study, showing a reduction in time (days) to negativity of infectious virus isolation in nasopharyngeal swabs from participants with symptomatic SARS-CoV-2 infection, as determined by isolation in Vero cell line culture. This press release features multimedia.

Trials 69

Trials Virus RNA Research Laboratories 69

The Pharma Data

NOVEMBER 5, 2020

Regeneron announced today an update from the independent data monitoring committee (DMC) for the United Kingdom-based RECOVERY trial evaluating REGN-COV2 in hospitalized patients with COVID-19.

Hospitals 52

Hospitals Trials Clinical Trials Production 52

Broad Institute

DECEMBER 13, 2023

One study was led by senior authors Evan Macosko , an institute member at the Broad and associate professor and attending psychiatrist at Massachusetts General Hospital, and Fei Chen , a core institute member at the Broad and an assistant professor in the Department of Stem Cell and Regenerative Biology at Harvard University.

DNA 140

DNA Virus Research Engineering 140

The Pharma Data

JANUARY 7, 2021

7, 2021 — The American Red Cross is urging COVID-19 survivors to donate blood plasma for hospital patients who need it to recover. The Red Cross is especially asking those who have recovered from COVID-19 to give blood because more donors are needed to help hospital patients. THURSDAY, Jan. More Information. © 2021 HealthDay.

Hospitals 52

Hospitals Virus Production 52

The Pharma Data

JANUARY 6, 2021

6, 2021 — The American Red Cross is urging COVID-19 survivors to donate blood plasma for hospital patients who need it to recover. The Red Cross is especially asking those who have recovered from COVID-19 to give blood because more donors are needed to help hospital patients. WEDNESDAY, Jan. Those who donate between Jan.

Hospitals 52

Hospitals Virus Packaging Production 52

The Pharma Data

NOVEMBER 19, 2020

Emily Adhikari, medical director of perinatal infectious diseases at Parkland Hospital in Dallas. “Most women with asymptomatic or mild infection will be relieved to know that their babies are unlikely to be affected by the virus,” Adhikari said. At the start of the pandemic, the U.S. The findings were published online Nov.

Hospitals 52

Hospitals Virus Disease Research 52

The Pharma Data

DECEMBER 17, 2020

Among those under 18, the virus is easily spread by close contact with family members who have COVID-19 and at gatherings where people don’t wear masks, but going to school wasn’t linked to positive COVID-19 tests, according to the researchers. “We’ve got to play by the rules. The report was published Dec.

Virus 52

Virus Hospitals Disease Research 52

The Pharma Data

DECEMBER 29, 2020

“It was like she was experiencing a movie, like ‘Kill Bill,'” Dr. Hisam Goueli, a psychiatrist at South Oaks Hospital in N.Y., A British study of mental complications in 153 patients hospitalized with COVID-19 found that 10 people had “new-onset psychosis.” told the Times.

Virus 52

Virus Hospitals Immune Response Doctors 52

The Pharma Data

DECEMBER 3, 2020

The changes help the virus to multiply and eventually destroy the cells. Kidney Disease Leading Risk Factor for COVID-related Hospitalization. Investigators analyzed Geisinger Health System ’s electronic health records and found that chronic kidney disease is the leading risk factor for COVID-19 hospitalization.

Disease 52

Disease Research Virus Hospitals 52

The Pharma Data

JANUARY 11, 2021

The CoviLamp-PCR test is cost effective, easily deployable and can be run on multiple platforms, providing rapid results in a wide range of healthcare settings including physicians’ offices, urgent care clinics, and hospital emergency departments. To book a test, members of the public can visit www.cardiai.com.

Laboratories 52

Laboratories Virus Hospitals 52

The Pharma Data

JANUARY 13, 2021

. “Restoration of the missing beneficial bacteria might boost our immunity against SARS-CoV2 virus and hasten recovery from the disease,” she said. “Managing COVID-19 should not only aim at clearing the virus, but also restoring the gut microbiota.”

Virus 52

Virus Hospitals Disease Research 52

The Pharma Data

OCTOBER 26, 2020

Hasan Jafri , Chief Medical Officer of Aridis Pharmaceuticals, will be a speaker on a panel entitled “Direct Antivirals and Other Agents Against SARS-CoV2 Virus.” ” Panel: Direct Antivirals and Other Agents Against SARS-CoV2 Virus Date: Wednesday, October 28, 2020 Time: 10:30AM- 11:50AM ET.

Pharmaceuticals 52

Pharmaceuticals Virus Hospitals Clinical Trials 52

The Pharma Data

JANUARY 11, 2021

The COVID-19 vaccines work by teaching the immune system to protect against the virus, experts said. Neither of the two vaccines approved in the United States — made by Pfizer-BioNTech and Moderna — contains the live virus. Fahad Khalid, chief of hospital medicine at Penn State Health Hershey Medical Center in Hershey, Pa.,

Vaccine 52

Vaccine Virus DNA Doctors 52

Broad Institute

MAY 30, 2023

Then, I started working in shipping and handling, where I was responsible for shipping testing kits to schools, hospitals, and other places. What surprised you about working as a COVID-19 technician at the Broad?

Research 89

Research Medical Schools Doctors Science 89

The Pharma Data

JULY 8, 2021

“These are the people who are getting exposure to the virus day in and day out, and the vaccine protected them against getting the disease. Only 204 (5%) of the participants eventually tested positive for SARS-CoV-2, the virus that causes COVID-19.

Vaccine 52

Vaccine Virus Nurses Hospitals 52

The Pharma Data

NOVEMBER 10, 2020

In a statement, the FDA said its approval of the antibody treatment, called bamlanivimab, is solely for people newly infected with COVID-19 “who are at high risk for progressing to severe COVID-19 and/or hospitalization.” More Information. The New York Times Article. © 2020 HealthDay. All rights reserved.

Treatment 52

Treatment Government Hospitals FDA 52

Nvidia Developer: Drug Discovery

OCTOBER 5, 2021

Recently published in the Proceedings of the National Academy of Sciences , the research develops a deep learning model that determines the best drug combinations for fighting the virus, despite having relatively limited data. ComboNet is trained on drug combination synergy, single-drug antiviral activity, and drug-target interaction data.

Drugs 52

Drugs Virus Science Disease 52

The Pharma Data

AUGUST 16, 2021

Vaccination is our most effective means of preventing COVID-19 infection – especially severe disease and hospitalization – and its profound impact on protecting lives is indisputable. We continuously strive to stay at least one step ahead of the virus. today announced that they have submitted Phase 1 data to the U.S.

Vaccine 52

Vaccine FDA Virus Immune Response 52

The Pharma Data

NOVEMBER 22, 2020

The vaccine was effective at preventing COVID-19, with no hospitalizations or severe cases in people receiving it. They use mRNA that codes for the spike protein in the SARS-CoV-2 virus, which is embedded in a nanolipid particle—basically a minuscule fat molecule. Both the Pfizer-BioNTech and Moderna vaccines utilize mRNA technology.

Vaccine 52

Vaccine Virus Trials Regulations 52

The Pharma Data

DECEMBER 4, 2020

Boston Children’s Hospital’s emergency department (ED) observed a steep decline in asthma-related emergency visits last spring. The number of hospital admissions for asthma also declined, while the proportion of asthma-related emergency visits that required hospitalization remained similar to previous years.

Hospitals 52

Hospitals Doctors Virus Treatment 52

The Pharma Data

JANUARY 21, 2021

Researchers randomized patients to either 4,200 mg of IV-administered bamlanivimab or placebo and saw that after eight weeks of participant follow-up, the 965 participants who tested negative for the virus at baseline saw a 57 percent lower frequency of symptomatic COVID-19 in the drug arm compared to the placebo arm. James Miessler.

Nurses 52

Nurses Research Laboratories Laboratories Virus 52

Broad Institute

SEPTEMBER 17, 2024

A data science support role at Massachusetts General Hospital allowed her to take advantage of the programming skills she developed during her PhD, creating simulations and working in the high-performance computing environment. When you want to model how proteins interact with each other or with a virus, you can model that using GPUs.

Research 93

Research Science Engineering Virus 93

DrugBank

JUNE 13, 2024

This personalized approach can also improve patient compliance and potentially lower healthcare costs by minimizing the need for frequent dosing and reducing hospital readmission rates.    A key part of gene therapy is efficiently delivering the therapeutic genetic material directly into target cells.

Therapies 98

Therapies Drugs DNA Treatment 98

The Pharma Data

JANUARY 14, 2021

That includes interviewing people at area hospitals and from the Southwest China Wholesale Seafood Market suspected of being where the virus jumped from animals into humans, CBS News reported. The team will start work immediately to determine how Wuhan became the world’s first COVID-19 epicenter, the WHO said.

Government 52

Government Virus Hospitals International 52

The Pharma Data

FEBRUARY 23, 2022

. * In the VAT08 Phase 3 primary series trial, two doses of the Sanofi-GSK vaccine in seronegative populations demonstrated: * 100% efficacy against severe COVID-19 disease and hospitalizations * 75% efficacy against moderate or severe COVID-19 disease * 57.9% Favorable safety profile following both primary series and booster vaccinations.

Vaccine 52

Vaccine Virus Trials Immune Response 52

The Pharma Data

JULY 12, 2021

The Phase 3 portion of the global MOVe-OUT trial studying molnupiravir in non-hospitalized adult patients with laboratory-confirmed COVID-19 and at least one risk factor associated with poor disease outcomes is underway. About Molnupiravir.

Clinical Trials 52

Clinical Trials Laboratories Research Laboratories RNA 52

NIH Director's Blog: Drug Development

OCTOBER 27, 2020

Another promising strategy is drugs that target the proteins within human cells that the virus needs to infect, multiply, and spread. These studies narrowed the list to 73 human proteins that the virus depends on to replicate. That’s the strategy employed by remdesivir , the only antiviral drug currently authorized by the U.S.

Drug Development 52

Drug Development Drugs Virus Science 52

The Pharma Data

JUNE 22, 2023

Since the 1st of June 2022, the Long COVID Consortium, led by HUS Helsinki University Hospital, is working to elucidate the predisposing factors and mechanisms for the development of Long COVID Syndrome (LCS). The first year of the Long COVID project: What has been achieved? The lysosomes are full of digestive enzymes.

Hospitals 40

Hospitals Virus Research 40

The Pharma Data

DECEMBER 30, 2020

. About Test & Trace Corps The Test & Trace Corps is the City’s comprehensive effort to test, trace, and provide support for every case of COVID-19 and every person exposed to the virus that causes COVID-19. . View original content to download multimedia: [link].

Nurses 52

Nurses Hospitals Virus Licensing 52